Analysis of tumor vascularization in a mouse model of metastatic lung cancer

被引:0
|
作者
Ariunbuyan Sukhbaatar
Maya Sakamoto
Shiro Mori
Tetsuya Kodama
机构
[1] Graduate School of Biomedical Engineering,Laboratory of Biomedical Engineering for Cancer
[2] Tohoku University,Biomedical Engineering Cancer Research Center, Graduate School of Biomedical Engineering
[3] Tohoku University,Department of Oral Diagnosis
[4] Tohoku University Hospital,Department of Oral and Maxillofacial Surgery
[5] Tohoku University Hospital,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Therapies targeting tumor vasculature would improve the treatment of lung metastasis, although the early changes in vascular structure are incompletely understood. Here, we show that obstructive metastatic foci in lung arterioles decrease the pulmonary vascular network. To generate a mouse model of lung metastasis activation, luciferase-expressing tumor cells were inoculated into the subiliac lymph node (SiLN) of an MXH10/Mo-lpr/lpr mouse, and metastatic tumor cells in the lungs were activated by SiLN resection. Activation of metastases was monitored by in vivo bioluminescence imaging. Pulmonary blood vessel characteristics were analyzed using ex vivo micro-computed tomography. The enhanced permeability and retention (EPR) effect in neovasculature after tumor cell activation was evaluated from the accumulation of intravenously injected indocyanine green (ICG) liposomes. Metastatic foci in lung arterioles were investigated histologically. Micro-computed tomography revealed decreases in pulmonary blood vessel length, volume and number of branching nodes during the early stage of metastasis caused by metastatic foci. ICG liposome accumulation by the EPR effect was not detected. Histology identified metastatic foci in lung arterioles. The lack of an EPR effect after the formation of metastatic foci in lung arterioles makes conventional systemic chemotherapy ineffective for lung metastasis. Thus, alternative therapeutic methods of drug delivery are needed.
引用
收藏
相关论文
共 50 条
  • [31] Developing new mouse models of metastatic lung cancer
    Wells, Julie
    Maser, Richard S.
    McGee, Teresa
    Memishian, Wendy
    Doty, Rosalinda
    Bult, Carol J.
    CANCER RESEARCH, 2020, 80 (16)
  • [32] Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar
    Xi Feng Fei
    Quan Bin Zhang
    Jun Dong
    Yi Diao
    Zhi Min Wang
    Ru Jun Li
    Zi Cheng Wu
    Ai Dong Wang
    Qing Lan
    Shi Ming Zhang
    Qiang Huang
    Journal of Experimental & Clinical Cancer Research, 29
  • [33] Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar
    Fei, Xi Feng
    Zhang, Quan Bin
    Dong, Jun
    Diao, Yi
    Wang, Zhi Min
    Li, Ru Jun
    Wu, Zi Cheng
    Wang, Ai Dong
    Lan, Qing
    Zhang, Shi Ming
    Huang, Qiang
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29
  • [34] Quantification of Tumor Burden in a Genetically Engineered Mouse Model of Lung Cancer by Micro-CT and Automated Analysis
    Barck, Kai H.
    Bou-Reslan, Hani
    Rastogi, Ujjawal
    Sakhuja, Timothy
    Long, Jason E.
    Molina, Rafael
    Lima, Anthony
    Hamilton, Patricia
    Junttila, Melissa R.
    Johnson, Leisa
    Carano, Richard A. D.
    TRANSLATIONAL ONCOLOGY, 2015, 8 (02): : 126 - 135
  • [35] Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer
    Said, Neveen
    Smith, Steven
    Sanchez-Carbayo, Marta
    Theodorescu, Dan
    JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (01): : 132 - 147
  • [36] Quantitative Primary Tumor Indocyanine Green Measurements Predict Osteosarcoma Metastatic Lung Burden in a Mouse Model
    Fourman, Mitchell S.
    Mahjoub, Adel
    Mandell, Jon B.
    Yu, Shibing
    Tebbets, Jessica C.
    Crasto, Jared A.
    Alexander, Peter E.
    Weiss, Kurt R.
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2018, 476 (03) : 479 - 487
  • [37] Integrated analysis of scRNAseq and spatial omics in brain metastatic lung cancer tumor tissue
    Hirose, Haruka
    Tsuji, Takahiro
    Kojima, Yasuhiro
    Yoshizawa, Akihiko
    Arakawa, Yoshiki
    Ozasa, Hiroaki
    Wake, Hiroaki
    Shimamura, Teppei
    CANCER RESEARCH, 2024, 84 (06)
  • [38] Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer
    Huysentruyt, Leanne C.
    Shelton, Laura M.
    Seyfried, Thomas N.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (01) : 65 - 72
  • [39] Primary Tumor Resection Decelerates Disease Progression in an Orthotopic Mouse Model of Metastatic Prostate Cancer
    Linxweiler, Johannes
    Hajili, Turkan
    Zeuschner, Philip
    Menger, Michael D.
    Stoeckle, Michael
    Junker, Kerstin
    Saar, Matthias
    CANCERS, 2022, 14 (03)
  • [40] A pipeline for identification and validation of tumor-specific antigens in a mouse model of metastatic breast cancer
    DeVette, Christa I.
    Gundlapalli, Harika
    Lai, Shu-Chin Alicia
    McMurtrey, Curtis P.
    Hoover, Ashley R.
    Gurung, Hem R.
    Chen, Wei R.
    Welm, Alana L.
    Hildebrand, William H.
    ONCOIMMUNOLOGY, 2020, 9 (01):